OverviewSuggest Edit

Misonix, Inc. specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Its innovative, ultrasonic platforms for surgical applications include aspirators for the removal of both soft and hard tissue, instruments for laparoscopic cutting and coagulation, devices for wound cleansing and debridement, products for precision bone cutting and sculpting, and liposuction instrumentation for improving body aesthetics. The Company's portfolio of products are all based upon the unique properties of ultrasound and its ability to differentiate hard and soft tissue for different clinical requirements. 

TypePublic
Founded1959
HQFarmingdale, US
Websitemisonix.com
Employee Ratings3.4

Latest Updates

Employees (est.) (Dec 2017)92
Revenue (FY, 2018)$36.7 M(+35%)
Share Price (Mar 2019)$20

Misonix Office Locations

Misonix has an office in Farmingdale
Farmingdale, US (HQ)
1938 New Hwy
Show all (1)
Report incorrect company information

Misonix Financials and Metrics

Misonix Revenue

Misonix's revenue was reported to be $36.68 m in FY, 2018
USD

Revenue (Q2, 2019)

10.2m

Gross profit (Q2, 2019)

7.1m

Gross profit margin (Q2, 2019), %

70%

Net income (Q2, 2019)

(840.3k)

EBIT (Q2, 2019)

(858.7k)

Market capitalization (18-Mar-2019)

191.7m

Closing stock price (18-Mar-2019)

20.0

Cash (31-Dec-2018)

10.2m
Misonix's current market capitalization is $191.7 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

17.1m22.2m23.1m27.3m36.7m

Revenue growth, %

30%4%

Cost of goods sold

5.9m7.3m8.2m9.8m

Gross profit

11.1m14.9m19.1m26.9m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

3.1m4.1m4.3m4.5m5.6m5.3m5.3m6.0m5.4m6.2m6.0m7.2m7.3m8.3m12.4m9.4m10.2m

Cost of goods sold

1.3m1.2m1.4m1.6m1.8m1.7m1.8m1.9m1.9m2.8m3.0m

Gross profit

1.7m2.9m2.9m3.0m3.8m3.6m3.5m4.1m3.6m6.6m7.1m

Gross profit Margin, %

56%70%67%65%68%69%66%68%66%71%70%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

7.0m9.6m9.0m11.6m11.0m

Accounts Receivable

Inventories

4.2m4.3m5.8m5.0m5.0m

Current Assets

15.4m21.0m19.3m22.6m21.9m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

4.7m5.0m5.6m7.6m8.3m8.9m9.7m9.6m8.4m8.6m12.8m11.9m10.5m12.1m12.3m9.3m10.2m

Inventories

4.2m4.0m4.1m4.5m4.3m4.2m4.8m5.4m5.9m5.2m5.0m4.9m5.2m5.0m5.2m4.9m5.7m

Current Assets

11.9m12.1m13.1m15.7m16.3m17.1m20.9m19.4m19.0m18.1m21.8m21.8m20.4m21.8m22.8m20.4m22.2m

PP&E

1.2m1.3m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

1.4m5.6m

Depreciation and Amortization

1.4m

Inventories

(1.0m)(1.3m)(2.8m)(873.1k)(1.4m)

Accounts Payable

Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

383.2k901.2k454.3k(521.9k)(614.8k)(8.1m)(5.8m)(2.6m)(3.5m)

Depreciation and Amortization

366.6k767.1k

Inventories

(146.6k)40.6k(733.7k)(517.3k)(476.1k)(797.0k)(834.6k)(1.8m)(2.6m)164.1k(116.9k)(450.0k)(649.4k)(839.4k)(1.2m)(104.1k)(1.2m)

Accounts Payable

64.5k377.4k137.9k
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

Misonix News and Updates

Misonix Fiscal 2019 Second Quarter Revenue Rises 22% to a Record $10.2 Million

FARMINGDALE, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today reported financial results for the fiscal 2019 second quarter ended December…

Misonix to Report Fiscal 2019 First Quarter Financial Results and Host Conference Call and Webcast on November 8

FARMINGDALE, N.Y., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report its fiscal 2019 first quarter financial result…

Misonix Demonstrates neXus, the First Fully Integrated, Smart Technology Ultrasonic Surgical Aspirator Platform at NASS 2018 Annual Meeting

FARMINGDALE, N.Y., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or “the Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, demonstrated for the first time publicly its next generation platform technology,…

Misonix to Present at the 38th Annual Canaccord Genuity Growth Conference on August 8

FARMINGDALE, N.Y., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participating in the Canaccord Genuity 38th Annual…
Report incorrect company information

Misonix Frequently Asked Questions

  • When was Misonix founded?

    Misonix was founded in 1959.

  • How many employees does Misonix have?

    Misonix has 92 employees.

  • What is Misonix revenue?

    Latest Misonix annual revenue is $36.7 m.

  • What is Misonix revenue per employee?

    Latest Misonix revenue per employee is $398.7 k.

  • Who are Misonix competitors?

    Competitors of Misonix include Microbot Medical, Ethicon and Biom'Up.

  • Where is Misonix headquarters?

    Misonix headquarters is located at 1938 New Hwy, Farmingdale.

  • Where are Misonix offices?

    Misonix has an office in Farmingdale.

  • How many offices does Misonix have?

    Misonix has 1 office.